Title: Monoclonal antibody binding to EGFR

 

Tools: VMD, 3ds Max, After Effects

Target Audience: Biomedical researchers and investors

Background: The epidermal growth factor receptor (EGFR) is a cell surface receptor commonly targeted in cancer therapy. The activation of EGFR gives signals that cause the cells to grow and proliferate. This illustration was based on the mechanism of action of cetuximab, which binds to EGFR to inhibit cell growth signals.

References

Li, S., Schmitz, K. R., Jeffrey, P. D., Wiltzius, J. J., Kussie, P., & Ferguson, K. M. (2005). Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell, 7(4), 301-311. 

Sliwkowski, M. X., & Mellman, I. (2013). Antibody therapeutics in cancer. Science (New York, N.Y.), 341(6151), 1192-1198.

Get in touch
I would love to collaborate with you, call me or drop me a note and let's find the visual solution to the story you want to tell.
(309) 740-8373 
 
  • LinkedIn - White Circle
  • Vimeo - White Circle
  • Twitter - White Circle

All contents © 2021 by Grace Hsu.